Unified Transcriptomic Melanoma Reference Map Reveals Predictive Molecular Signatures for Patient Prognosis
ISEF · 2026 Translational Medical Science
Overview
Melanoma is the most fatal type of skin cancer, taking over 50,000 lives annually. While advances in checkpoint immunotherapy have decreased mortality rates, it is difficult to determine which patients will benefit from treatment, and how tumor biology predicts prognosis. Studies have published bulk RNA-seq datasets for melanoma; however, these datasets have never been unified to decode underlying molecular processes in a generalizable manner. In this study, I combined seven datasets representing 1,040 patient samples and created a transcriptomic reference map using dimension reduction via Uniform Manifold Approximation and Projection (UMAP). Analysis of tumor samples from the same patient before vs. during immunotherapy revealed transcriptomic changes which I used to create a predictive gene signature for immunotherapy response. I compared regions of the UMAP based on sample proximity using hierarchical clustering and identified areas with distinct biological features. The keratinocyte-enriched region correlated with poor prognosis, whereas the immune activated region correlated with good prognosis. Finally, I analyzed chromosome arm-level changes and found that increased aneuploidy correlated with poor survival. Based on these novel biological findings, I ultimately created an XGboost-based machine learning model to predict a given patient's response to immunotherapy and survival, with an AUROC of 0.88. Finally, I integrated my findings into a free web-based tool available for clinicians and researchers without computational training to make new discoveries and potentially guide patient treatment decisions. This work redefines melanoma precision medicine, increasing predictability and understanding of patients' underlying tumor biology and treatment response.
Awards (1)
- Second Award of $2,400 $2,400
Competition history
- ISEF 2026
Resources
Related projects
ISEF · 2024
Machine Learning Approaches To Determine Clinical Factors for Prediction of Immune Factors in Melanoma
ISEF · 2023
Identifying Relationships Between the Gut Microbiome and Melanoma Patients' Responses to Immunotherapy Using Machine Learning Techniques
ISEF · 2021
Machine Learning to Predict Response to Anti-PD1 in Melanoma Using Genetic Biomarkers
ISEF · 2025
Spatial Transcriptomics and Adaptive Multi-Modal Encoding: A Novel Approach to Early Metastasis Profiling and Therapeutic Targeting Treatment
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair